SPAG9 Antibody, HRP conjugated

1. AKAP4 and SPAG9 genes may find use as diagnostic biomarkers for CRC. PMID: 29480665
2. Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer PMID: 27655714
3. SPAG9 mRNA and protein overexpression in lung cancer tissue, and the presence of SPAG9 IgG antibody in peripheral blood of lung cancer patients indicates that it has potential as a biomarker for lung cancer diagnosis. PMID: 26934841
4. SPAG9-elevated expression contributes to malignant behavior and poor prognosis of breast cancer and may support a potential indicator in treatment selection. PMID: 26631164
5. Study suggest that suppression of miR-141 may cause an aberrant overexpression of SPAG9 promoting growth and metastasis of hepatocellular carcinoma cells. PMID: 26790956
6. expression of SPAG9 in ECC cells with TGF-beta1 treatment and spheroids formation was increased PMID: 27352556
7. PLK1 binding to JIP4 was found in G2 phase and mitosis, and PLK1 binding was self-primed by PLK1 phosphorylation of JIP4. PMID: 26291670
8. Based on in vitro assays, we found miR-200a-3p significantly inhibit cancer cell proliferation by inducing apoptosis. PMID: 26797273
9. FOXK1 protein levels and activity are regulated by associating with JLP and PLK1 PMID: 26468278
10. SPAG9 overexpression in gastric cancer correlates with poor prognosis and contributes to gastric cancer cell proliferation PMID: 26293216
11. SPAG9 was upregulated in nonmelanoma skin cancer when compared with normal skin. PMID: 25033008
12. SPAG9 expression is significantly increased in prostate cancer and it may be involved in the process of prostate cancer cell motility, migration and angiogenesis. PMID: 25310386
13. knockdown of Sec8 enhances the binding of JIP4 to MAPK kinase 4, thereby decreasing the phosphorylation of MAPK kinase 4, JNK, and p38. PMID: 25244576
14. SPAG9 upregulates PODXL expression in human astrocytoma cells at the PODXL gene promoter/transcriptional level through a JNKdependent mechanism. PMID: 24788963
15. SPAG9 is overexpressed in human HCC and serves as a prognostic marker. SPAG9 contributes to cancer cell growth through regulation of cyclin proteins. PMID: 24801907
16. SPAG9 is overexpressed in human prostate cancers and contributes to prostate cancer cell growth, possibly through cyclin protein regulation. PMID: 24740566
17. down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells, suggesting that SPAG9 may be a potential target for therapeutic use. PMID: 24330581
18. data in clinical specimens indicated that SPAG9 is potential biomarker and therapeutic target for bladder TCC. PMID: 24349057
19. High SPAG9 expression is associated with endometrial cancer. PMID: 24460345
20. SPAG9 depletion could inhibit the activity of p-JNK. PMID: 23711689
21. SPAG9 serves as an important oncoprotein in human astrocytoma by regulating cell proliferation and invasion. PMID: 23696027
22. SPAG9 is positively expressed in endometrial cancer, and with a high humoral immune response in patients. It may serve as a new type of endometrial cancer markers for early detection, diagnosis and treatment. PMID: 22146769
23. These findings collectively suggest that SPAG9 may have a role in tumor development and early spread. PMID: 21356354
24. N-cadherin expression had an inhibitory effect on JLP-mediated p38 MAPK signal activation by decreasing the interaction between JLP and p38 MAPK PMID: 21177868
25. SPAG9 mRNA& protein are expressed in CML patients (88%) and in K562 & KCL-22 cells. 90% CML chronic-phase patients showed humoral response against SPAG9. PMID: 20138665
26. SPAG9 protein is found in the equatorial plate and flagella of human spermatozoa. PMID: 19947555
27. Testicular antigen PHET is an auutoantigen recognized by sera from systemic sclerosis (SSc) patients with extensive fibrotic changes; the autoantibody response to PHET is induced by ectopic overexpression of PHET in dermal fibroblasts of SSc patients. PMID: 14662895
28. first report of sperm-associated JNK-binding protein (SPAG9) that may have a role in spermatozoa-egg interaction PMID: 15693750
29. SPAG9 is a new member of c-Jun NH2 -terminal kinase (JNK) interacting protein exclusively expressed in testis PMID: 16077255
30. The present investigation will eventually extend the application of SPAG9 siRNA in in vivo targeting experiments that aim to define the SPAG9 functional genomics in tumor and reproductive biology. PMID: 16356479
31. Recombinant human protein is adsorbed on alum is highly immunogenic in macaca model and therefore represents a suitable sperm-based vaccine immunogen for fertility trials in macaque. PMID: 16959808
32. SPAG9 may have a role in tumor development and metastasis and thus could serve as a novel target for early detection and treatment of renal cell carcinoma. PMID: 18922895
33. Kinesin adapter JLP links PIKfyve to microtubule-based endosome-to-trans-Golgi network traffic of furin. PMID: 19056739
34. structural analysis of ARF6 in a complex with JIP4 PMID: 19644450
35. Findings support a potential role for SPAG9 as diagnostic biomarker as well as a possible therapeutic target in thyroid cancer treatment. PMID: 19820019

Show More

Hide All

HGNC: 14524

OMIM: 605430

KEGG: hsa:9043

STRING: 9606.ENSP00000262013

UniGene: Hs.463439